Atlas Trials

A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis

Clinical trial NCT02545907 · COMPLETED

Trial details

NCT number
NCT02545907
Sponsor
University College, London
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Amyloidosis
Start date
2017-09-14
Primary completion
2019-09-26
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.